About the Formulation Technologies Session
- Formulation And Analytical Development Of New Modalities
- Excipient And Preservative Issues
- Polysorbate Issues And New Excipients
- New Developments In Lyophilization And Alternative Drying Techniques
- Developability, Robustness, And Scale-Up
A formulation is the composition of a drug product that contains an active pharmaceutical ingredient (API) and other inactive ingredients. Every inactive ingredient used in the formulation will serve specific purposes to ensure product performance and conformance
Formulation Technology is useful to facilitate the delivery of a therapeutic compound, which is useful to optimize the absorption or distribution of therapeutic compounds in the body, but that is not itself a therapeutic compound provided. Formulation Technology may exclude any technology that comprises a chemical modification of the Peptide, or Hematide.
Featured Speakers — Formulation Technologies 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Formulation Technologies Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at PDDS 2027
Why Attend the Formulation Technologies Conference 2027
Present Your Research
Oral and poster slots for original Formulation Technologies work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Learn from Keynotes
Plenary lectures from leading voices shaping Formulation Technologies research and practice.
Hybrid Flexibility
Attend in person in Valencia or join virtually — same program, same certificate.
Join PDDS 2027 for the Formulation Technologies track
Oral and poster slots for your work — in person in Valencia or online. Not presenting? Attend as a delegate to learn from the field.
Formulation Technologies Conference 2027 — FAQs
What is the Formulation Technologies track at PDDS 2027?
The Formulation Technologies track is a dedicated stream within PDDS 2027 covering the latest research, clinical innovation, and best practice in Formulation Technologies. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Formulation Technologies sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Formulation Technologies are all welcome — whether presenting or attending.
Can I present my research in the Formulation Technologies track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Is virtual attendance available for Formulation Technologies sessions?
Yes. PDDS 2027 is a hybrid conference — attend the Formulation Technologies track in person in Valencia or join live online, with on-demand access afterward.
Join the PDDS 2027 delegation
Valencia · September 13–15, 2027 · Hybrid · in-person & virtual
Attend without presenting.